Plain-English translation of NCT06195267 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a medication called can help protect your lungs and organs after you have emergency heart surgery for a serious aortic condition. The study focuses on preventing a dangerous inflammatory response that sometimes happens after surgery, which can damage multiple organs. Researchers want to see if giving this medication during the acute phase of your condition will reduce these serious complications.
After major heart surgery, some patients develop a severe inflammatory response that can damage the lungs and other vital organs, sometimes fatally. This study aims to find out whether this medication can prevent that dangerous inflammatory cascade and improve patient outcomes.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will either receive the medication during and after your emergency heart surgery, or be in a control group that receives standard care without this medication. The study will track your lung function and organ health closely after surgery to see whether the medication helps prevent complications. You'll be monitored as part of your regular surgical recovery care, with researchers comparing outcomes between the two groups.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
China